Abstract
Cyclosporin A (CSA) has been used in an attempt to suppress the primary immune response of HgA(A)-negative rabbits to A-positive red cells. The immune response was assessed by measuring the survival of a small intravenous (i.v.) dose of 51Cr-labelled A-positive cells and by testing the serum of the immunized rabbits for anti-A. In one experiment, eight A-negative rabbits were given a first i.v. injection of A-positive red cells, and CSA (25 mg/kg/day) in olive oil was given by mouth for 17-34 days. There was no evidence of impaired alloimmunization compared with the responses in control animals treated with olive oil alone. In a second experiment, eight A-negative rabbits were given a first injection of A-positive muscularly (i.m.), and CSA (25 mg/kg/day) in miglyol was given by im.m. injection for 10 days. Six of these rabbits were rendered unresponsive, and the remaining two, who showed impaired survival of the monitoring red cells, produced only low anit-A titres. Seven out of eight controls given i.m. miglyol without CSA responded with good anti-A production. Rabbits that were unresponsive to A-positive red cells responded normally to sheep red blood cells 15 weeks after CSA treatment. Higher serum levels of CSA were found following i.m. administration of the drug but treatment by this route as associated with severe toxicity in some rabbits.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
- COHEN C. On blood groups and confusion in the rabbit. Transplant Bull. 1958 Jan;5(1):21–23. doi: 10.1097/00007890-195801000-00009. [DOI] [PubMed] [Google Scholar]
- Calne R. Y., Rolles K., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Henderson R. G., Aziz S. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979 Nov 17;2(8151):1033–1036. doi: 10.1016/s0140-6736(79)92440-1. [DOI] [PubMed] [Google Scholar]
- Dunn D. C., White D. J., Herbertson B. M., Wade J. Prolongation of kidney survival during and after cyclosporin A therapy. Transplantation. 1979 May;27(5):359–361. doi: 10.1097/00007890-197905000-00018. [DOI] [PubMed] [Google Scholar]
- Garby L., Mollison P. L. Deduction of mean red-cell life-span from 51Cr survival curves. Br J Haematol. 1971 May;20(5):527–536. doi: 10.1111/j.1365-2141.1971.tb07068.x. [DOI] [PubMed] [Google Scholar]
- Green C. J., Allison A. C. Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet. 1978 Jun 3;1(8075):1182–1183. doi: 10.1016/s0140-6736(78)90970-4. [DOI] [PubMed] [Google Scholar]
- Green C. J., Allison A. C., Precious S. Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin-A treatment. Lancet. 1979 Jul 21;2(8134):123–125. doi: 10.1016/s0140-6736(79)90005-9. [DOI] [PubMed] [Google Scholar]
- Powles R. L., Clink H. M., Spence D., Morgenstern G., Watson J. G., Selby P. J., Woods M., Barrett A., Jameson B., Sloane J. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet. 1980 Feb 16;1(8164):327–329. doi: 10.1016/s0140-6736(80)90881-8. [DOI] [PubMed] [Google Scholar]
- Smith G. N., Mollison P. L. Normal red cell survival in the rabbit. Scand J Haematol. 1973;11(3):188–194. doi: 10.1111/j.1600-0609.1973.tb00115.x. [DOI] [PubMed] [Google Scholar]
- Smith G. N., Mollison P. L. Responses in rabbits to the red cell alloantigen HgA. Immunology. 1974 May;26(5):865–875. [PMC free article] [PubMed] [Google Scholar]